Transcatheter closure of a large patent ductus arteriosus with severe pulmonary arterial hypertension in a child
Yükleniyor...
Dosyalar
Tarih
2013
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Herz
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Patent ductus arteriosus (PDA) is one
of the first congenital heart diseases to
have been treated via the transcatheter
technique. The first reported interventional
closure was performed by Porstmann
et al. [1] in 1971, followed by that
of Rashkind and Cuaso. Since then, various
devices have been used, such as the
Gianturco coils, detachable coils, Flipper
coils, Duct-Occlud coils, and Nit-Occlud
coils. Over the last decade, clinical experience
with transcatheter device closure
of PDA has increased with various devices.
In 1998, the Amplatzer duct occluder
(ADO; AGA Medical Corp., MN, USA)
was introduced, which has become the
most frequently used device for closure of
moderate to large PDAs. However, transcatheter
closure of large PDAs with severe
pulmonary hypertension still remains
problematic. Treatment decision and device
choice should be made after angiographic
evaluation of the PDA, hemodynamic
assessment, vasoreactivity testing,
or transient balloon occlusion.
In this report, we present a problematic
transcatheter closure of a large PDA
with severe pulmonary hypertension in
an 8-year-old girl.
Açıklama
Anahtar Kelimeler
Kaynak
Herz
WoS Q Değeri
Scopus Q Değeri
Cilt
38
Sayı
Künye
Karakurt, C. Elkıran, Ö. Çelik, S. F. Koçak, G. (2013). Transcatheter closure of a large patent ductus arteriosus with severe pulmonary arterial hypertension in a child. Herz. 38:685–688.
